Susquehanna International Group
BCLI

Susquehanna International Group’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Hold
0
6177
2024
Q3
Hold
0
5667
2024
Q2
Sell
-26,544
Closed -$15K 5681
2024
Q1
$15K Buy
26,544
+1,713
+7% +$967 ﹤0.01% 5326
2023
Q4
$6.78K Buy
+24,831
New +$6.78K ﹤0.01% 5759
2023
Q3
Sell
-505,799
Closed -$1.04M 5572
2023
Q2
$1.04M Buy
505,799
+104,046
+26% +$214K ﹤0.01% 2655
2023
Q1
$1.33M Buy
401,753
+295,682
+279% +$976K ﹤0.01% 2493
2022
Q4
$174K Buy
+106,071
New +$174K ﹤0.01% 4589
2022
Q3
Sell
-15,323
Closed -$42K 6124
2022
Q2
$42K Sell
15,323
-79,277
-84% -$217K ﹤0.01% 5278
2022
Q1
$318K Buy
+94,600
New +$318K ﹤0.01% 4283
2021
Q4
Sell
-39,031
Closed -$129K 5826
2021
Q3
$129K Buy
+39,031
New +$129K ﹤0.01% 4897
2021
Q2
Sell
-284,519
Closed -$1.09M 5327
2021
Q1
$1.09M Sell
284,519
-86,130
-23% -$330K ﹤0.01% 2881
2020
Q4
$1.68M Buy
+370,649
New +$1.68M ﹤0.01% 1922
2020
Q3
Hold
0
4419
2020
Q2
Hold
0
4262
2020
Q1
Sell
-65,306
Closed -$280K 4544
2019
Q4
$280K Sell
65,306
-33,010
-34% -$142K ﹤0.01% 3205
2019
Q3
$383K Buy
98,316
+17,207
+21% +$67K ﹤0.01% 3165
2019
Q2
$320K Buy
81,109
+31,096
+62% +$123K ﹤0.01% 3396
2019
Q1
$217K Buy
50,013
+21,974
+78% +$95.3K ﹤0.01% 2485
2018
Q4
$100K Buy
28,039
+8,758
+45% +$31.2K ﹤0.01% 3190
2018
Q3
$74K Buy
19,281
+7,630
+65% +$29.3K ﹤0.01% 3004
2018
Q2
$45K Buy
+11,651
New +$45K ﹤0.01% 3432
2018
Q1
Sell
-53,623
Closed -$210K 3410
2017
Q4
$210K Buy
53,623
+17,731
+49% +$69.4K ﹤0.01% 3098
2017
Q3
$148K Buy
+35,892
New +$148K ﹤0.01% 2829
2017
Q2
Hold
0
3546
2017
Q1
Hold
0
3298
2016
Q4
Sell
-21,400
Closed -$51K 4166
2016
Q3
$51K Buy
+21,400
New +$51K ﹤0.01% 2776
2016
Q2
Sell
-18,733
Closed -$50K 3209
2016
Q1
$50K Buy
+18,733
New +$50K ﹤0.01% 3651
2015
Q4
Hold
0
4230
2015
Q3
Hold
0
4159